RITA TSIPEN: Open Payments
NPI 1740727858 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,946 in 57 payments from 14 companies in 2025. Trend: 2023 $903 · 2024 $918 · 2025 $1,946
Food & beverage: $1,946
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 12 | $608 |
| Arcutis Biotherapeutics, Inc. | 13 | $472 |
| GENZYME CORPORATION | 1 | $150 |
| Novartis Pharmaceuticals Corporation | 4 | $118 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $106 |
| LEO Pharma Inc. | 4 | $77 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $72 |
| Verrica Pharmaceuticals Inc. | 3 | $69 |
| Botanix SB Inc | 2 | $66 |
| Lilly USA, LLC | 3 | $59 |
Products named: Opzelura, Zoryve, DUPIXENT, Winlevi, YCANTH, SOFDRA, ADBRY, COSENTYX.
Industry payments across NY — which companies pay providers there.
